All results
3 results for phase ii 16 week double blind placebo controlled parallel group randomized
-
Clinical Trials
This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…
-
News, Stories & Blog
Part 2 of our “Year in Review” focuses on the hospitals, research institutes and centers that are part of the UF Health family: UF Health Cancer Center UF…
-
Clinical Trials
160 subjects with autoimmune pulmonary alveolar proteinosis (aPAP) will be randomized to receive once daily treatment with inhaled molgramostim or placebo for…